Neurones (NRO.PA) Stock Price

Neurones Price

Euronext·CLOSED
36.15
​
Market closed

Revenue has compounded at 10.4% per year over the past 19 years to 857.20 M EUR. Earnings per share have grown at 11.5% per year over the last 19 years. Neurones's net margin stands at 6.1%, broadly stable from 6.5% several years earlier. Neurones currently offers a dividend yield of about 3.60%. The payout ratio is around 61% of earnings. The dividend has grown at 17.6% per year over the past 19 years. Analysts set a median price target of 53.04 EUR, implying 46.7% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Neurones stock price

Access this data via the Eulerpool API

Neurones business model & stock analysis

Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services.

Frequently asked questions about Neurones

The business model of Neurones SA revolves around providing IT services and solutions to various industries. Neurones SA offers a wide range of services including consulting, system integration, infrastructure management, and software solutions. The company focuses on developing innovative and cost-effective IT solutions to help their clients optimize their business processes and improve overall performance. Neurones SA aims to meet the evolving technology needs of its clients by staying updated with the latest advancements in the IT sector. With its expertise and experience, Neurones SA strives to deliver high-quality IT services and solutions tailored to the specific requirements of each client.

Neurones SA is primarily active in the IT and management consulting industries.

The main competitors of Neurones SA in the market include Atos, Capgemini, and Sopra Steria.

Neurones SA is a renowned French IT services company established in 1984. With over 30 years of experience, Neurones has become a leading player in the industry, delivering innovative digital solutions to a wide range of clients. Initially focused on mainframe computer services, the company quickly expanded its expertise to cover emerging technologies, such as internet and e-business solutions, as well as information systems security. Neurones SA delivers high-quality services encompassing consulting, systems integration, infrastructure management, and outsourcing. Through strategic partnerships, continuous innovation, and a talented workforce, Neurones SA has solidified its position as a trusted provider of IT solutions globally.

Some significant milestones achieved by Neurones SA include its creation in 1985, listing on the Paris Stock Exchange in 1999, and being recognized as a key player in digital transformation services. The company has consistently expanded its expertise in areas such as digital services, cybersecurity, and artificial intelligence. Neurones SA has also formed strategic partnerships and made numerous acquisitions to strengthen its position in the market. With a strong track record of delivering innovative solutions to its clients, the company continues to thrive and contribute to the advancement of technology-driven businesses.

Neurones SA is primarily present in France, where the company is headquartered. As a leading French IT services and consulting firm, Neurones SA has established a strong presence in various regions across the country. With a focus on delivering innovative solutions and expertise in digital transformation, Neurones SA has expanded its operations in other countries as well. While primarily present in France, the company also has a presence in other European countries, including Belgium, Luxembourg, and Switzerland. Neurones SA's commitment to providing cutting-edge technology solutions has allowed them to become a trusted partner for businesses not only in France but also in select international markets.

Neurones SA represents a strong set of values and a clear corporate philosophy. The company values include excellence, innovation, and commitment. Neurones SA strives for excellence in all areas of its business, ensuring high-quality services and solutions for its clients. The company fosters innovation, constantly seeking new ways to improve and adapt to the rapidly changing business landscape. Neurones SA also emphasizes commitment, both towards its clients and its employees, fostering strong and long-lasting relationships. Overall, Neurones SA prides itself on being a trustworthy and reliable partner, driven by its values and corporate philosophy.

Analysts currently set an average price target of 53.04 EUR for the Neurones stock (median: 53.04 EUR), implying +47.7 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Neurones stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Neurones to generate revenue of 917.20 M EUR and earnings per share of 2.33 EUR.

The Neurones share (NRO.PA) is listed on 6 stock exchanges, including: London (0GX2.L), Frankfurt (NE9.F), München (NE9.MU), Paris (NRO.PA).

The company Neurones SA is a large company that offers various services in the field of IT and digital transformation. The company was founded in 1989 and is headquartered in France. Neurones SA's services are used by companies of all sizes and industries. The business model of Neurones SA is based on three pillars: Professional Services, Software, and Transformation. Professional Services include consulting, planning, and implementation of IT projects. The company works in partnership with customers to develop and implement customized solutions for their business needs. Neurones SA also offers outsourcing services to facilitate the operation of IT systems for customers. The software division of Neurones SA includes products and solutions developed by the company. The main products include cybersecurity solutions to help customers protect their systems and data from threats. The company also offers software tools that can improve the efficiency of IT systems and reduce costs. These solutions are used by companies of all sizes and industries to optimize their business processes. The third pillar of Neurones SA's business model is transformation. The company believes that the digitalization of society and the economy requires transformation. This involves adapting business models and introducing new technologies to remain competitive. Neurones SA provides consulting and implementation services to support companies in their digital transformation. The company works with its customers to rethink business processes, introduce new technologies such as artificial intelligence and blockchain, and support employees in adapting to new work methods and tools. Neurones SA offers a wide range of services that are used by medium-sized companies to large multinational corporations in various industries. The company's broad portfolio allows it to meet the individual needs of each customer with its services. The company operates in Europe and North Africa and has a network of over 8,000 experts in various fields. Neurones SA's employees are highly qualified IT specialists, consultants, and project managers who work closely with customers to develop customized business solutions. In summary, Neurones SA's business model is based on three pillars: Professional Services, Software, and Transformation. With its wide range of services and products, the company has achieved a strong position in the market for IT consulting and digital transformation. The company works closely with its customers to develop customized solutions for their business needs. The company operates in Europe and North Africa and offers its customers a wide range of services ranging from consulting and planning to implementation and operation.

The expected revenue of Neurones is 917.20 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Neurones is 56.70 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Neurones is currently 15.51. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Neurones stock.

The price-to-sales ratio (P/S) of Neurones is currently 0.96. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Neurones stock.

The Eulerpool Quality Score for Neurones is 7/10.

The ISIN of Neurones is FR0004050250. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Neurones is 938282. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Neurones is NRO.PA. The ticker symbol is used to trade Neurones shares on the stock exchange.

Fair ValueTerminal
32.54 EUR
Over-/UndervaluationTerminal
Fairly valued
Industry
IT Services
Number of shares
Employees
Revenue per Employee
159,568.13 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website neurones.net
Country
Currency
EUR
Initial public offering
May 23, 2000
ISIN
FR0004050250
Cusip
F6523H101
Sedol
5972676
Market capitalization
880.12 M EURSmall Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
2.34
P/E ratio
P/Ee 2026
15.52
P/Ee 2027
13.91
P/Ee 2028
12.60
P/S
P/Se
0.96
EV/EBIT
7.97
P/B Ratio
2.20
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
11.92 %
Gross Margin
10.50 %
EBIT Margin
8.44 %
Net Margin
6.07 %
EPS (Earnings Per Share)
2.14 EUR
Net Debt / EBIT
-4.20
Debt/Equity
0.09
Dividend
Dividend yield
3.60 %
Est. Dividend Yield
3.87 %
Payout Ratio
60.73 %
Dividend growth Ø5Y
6.96 %
Dividend payments per year
1
Dividend paid since
21 years
Dividend not reduced since
3 years
Dividend increased since
3 years
Dividend withholding tax
25.00 %
Last updated Oct 2, 2026, 2:38 PM

Neurones Ticker

EURONEXT · NRO.PAFRANKFURT · NE9.FLONDON · 0GX2.LLONDON STOCK EXCHANGE · 0GX2.LMUNICH · NE9.MUPARIS · NRO.PA

Neurones FIGI

NE9:GR · BBG000BVVWX7NE9:GF · BBG000BVVX29NE9:GS · BBG000BVVY45NE9:GM · BBG000BVVYF3NE9:GB · BBG000BVVZ51NRO:FP · BBG000CV9MR0NRO:EO · BBG000J566G0NRO:XH · BBG000J56965NRO:XC · BBG000J56BB4NRO:XF · BBG000J56BW1NRO:XE · BBG000J56DD8NRO:XJ · BBG000J56DN7

All fundamentals and in-depth analysis of Neurones

Our stock analysis for Neurones stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neurones. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.